These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15942778)

  • 1. The importance of non-invasive genetic analysis in the initial diagnostics of Alport syndrome in young patients.
    Slajpah M; Meglic A; Furlan P; Glavac D
    Pediatr Nephrol; 2005 Sep; 20(9):1260-4. PubMed ID: 15942778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of mutations in the COL4A5 collagen gene in Alport syndrome.
    Barker DF; Hostikka SL; Zhou J; Chow LT; Oliphant AR; Gerken SC; Gregory MC; Skolnick MH; Atkin CL; Tryggvason K
    Science; 1990 Jun; 248(4960):1224-7. PubMed ID: 2349482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome.
    Nagel M; Nagorka S; Gross O
    Hum Mutat; 2005 Jul; 26(1):60. PubMed ID: 15954103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alport syndrome: from bedside to genome to bedside.
    Kashtan CE; Michael AF
    Am J Kidney Dis; 1993 Nov; 22(5):627-40. PubMed ID: 8238007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Mutation in a Kazakh Family with X-Linked Alport Syndrome.
    Baikara BT; Zholdybayeva EV; Rakhimova SE; Nigmatullina NB; Momynaliev KT; Ramanculov YM
    PLoS One; 2015; 10(7):e0132010. PubMed ID: 26168235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and molecular diagnosis of Alport syndrome.
    Kashtan CE
    Proc Assoc Am Physicians; 1995 Oct; 107(3):306-13. PubMed ID: 8608415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and genetic features of the Alport 'syndromes'].
    Pescucci C; Longo I; Mari F; Scala E; Bruttini M; Caselli R; Renieri A
    G Ital Nefrol; 2005; 22(5):466-76. PubMed ID: 16267804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collagen type IV-related nephropathies in Portugal: pathogenic COL4A5 mutations and clinical characterization of 22 families.
    Nabais Sá MJ; Sampaio S; Oliveira A; Alves S; Moura CP; Silva SE; Castro R; Araújo JA; Rodrigues M; Neves F; Seabra J; Soares C; Gaspar MA; Tavares I; Freitas L; Sousa TC; Henriques AC; Costa FT; Morgado E; Sousa FT; Sousa JP; da Costa AG; Filipe R; Garrido J; Montalban J; Ponce P; Alves R; Faria B; Carvalho MF; Pestana M; Carvalho F; Oliveira JP
    Clin Genet; 2015 Nov; 88(5):462-7. PubMed ID: 25307721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical spectrum of type IV collagen mutations.
    Lemmink HH; Schröder CH; Monnens LA; Smeets HJ
    Hum Mutat; 1997; 9(6):477-99. PubMed ID: 9195222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome.
    Marcocci E; Uliana V; Bruttini M; Artuso R; Silengo MC; Zerial M; Bergesio F; Amoroso A; Savoldi S; Pennesi M; Giachino D; Rombolà G; Fogazzi GB; Rosatelli C; Martinhago CD; Carmellini M; Mancini R; Di Costanzo G; Longo I; Renieri A; Mari F
    Nephrol Dial Transplant; 2009 May; 24(5):1464-71. PubMed ID: 19129241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical Alport syndrome associated with a novel COL4A5 mutation.
    Höpker K; Liebau MC; Friederichsohn C; Waldherr R; Benzing T
    Clin Nephrol; 2009 Mar; 71(3):321-5. PubMed ID: 19281745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common ancestry of three Ashkenazi-American families with Alport syndrome and COL4A5 R1677Q.
    Barker DF; Denison JC; Atkin CL; Gregory MC
    Hum Genet; 1997 May; 99(5):681-4. PubMed ID: 9150741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of mutations in the COL4A5 gene by SSCP in X-linked Alport syndrome.
    Hertz JM; Juncker I; Persson U; Matthijs G; Schmidtke J; Petersen MB; Kjeldsen M; Gregersen N
    Hum Mutat; 2001 Aug; 18(2):141-8. PubMed ID: 11462238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Segregation of hematuria in thin basement membrane disease with haplotypes at the loci for Alport syndrome.
    Buzza M; Wilson D; Savige J
    Kidney Int; 2001 May; 59(5):1670-6. PubMed ID: 11318937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of Alport syndrome without biopsy?
    Gubler MC
    Pediatr Nephrol; 2007 May; 22(5):621-5. PubMed ID: 17143627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel Cys1638Tyr NC1 domain substitution in alpha5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities.
    Wilson JC; Yoon HS; Walker RJ; Eccles MR
    Nephrol Dial Transplant; 2007 May; 22(5):1338-46. PubMed ID: 17277342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of COL4A5 mutations in Finnish Alport syndrome patients.
    Martin P; Heiskari N; Pajari H; Grönhagen-Riska C; Kääriäinen H; Koskimies O; Tryggvason K
    Hum Mutat; 2000 Jun; 15(6):579. PubMed ID: 10862091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A large tandem duplication within the COL4A5 gene is responsible for the high prevalence of Alport syndrome in French Polynesia.
    Arrondel C; Deschênes G; Le Meur Y; Viau A; Cordonnier C; Fournier A; Amadeo S; Gubler MC; Antignac C; Heidet L
    Kidney Int; 2004 Jun; 65(6):2030-40. PubMed ID: 15149316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV α5 chain.
    Hashimura Y; Nozu K; Kaito H; Nakanishi K; Fu XJ; Ohtsubo H; Hashimoto F; Oka M; Ninchoji T; Ishimori S; Morisada N; Matsunoshita N; Kamiyoshi N; Yoshikawa N; Iijima K
    Kidney Int; 2014 May; 85(5):1208-13. PubMed ID: 24304881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.